Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
about
Losartan-induced Ischemic Hepatocellular Hepatotoxicity: A Case Report and Literature Review.Longitudinal Assessment of Renal Perfusion and Oxygenation in Transplant Donor-Recipient Pairs Using Arterial Spin Labeling and Blood Oxygen Level-Dependent Magnetic Resonance Imaging.A Pilot Study on the Effect of Angiotensin Receptor Blockers on Platelet Aggregation in Hypertensive Patients- A Prospective Observational Study.Small molecule angiotensin II type 2 receptor (AT₂R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats.
P2860
Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@en
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@nl
type
label
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@en
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@nl
prefLabel
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@en
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@nl
P2860
P356
P1476
Fifteen years of losartan: wha ...... ronic kidney disease patients?
@en
P2093
Ari Hirsch
Elizabeth Ripley
P2860
P356
10.2147/IJNRD.S7038
P407
P577
2010-06-28T00:00:00Z